Institutional investors purchased a net $3.0 million shares of MDCO during the quarter ended June 2014 and now own 104.35% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HSBC GLOBAL ASSET MANAGEMENT (DE... Bought 3.0 Thousand shares of Medicines Co
CREDIT SUISSE AG Bought 400.00 shares of Medicines Co
PHARUS MANAGEMENT SA Sold 10.0 Thousand shares of Medicines Co